BioQ Pharma Announces Marijn Dekkers as New Strategic Advisor to the Company

Jul 25, 2018
SAN FRANCISCO, July 25, 2018: BioQ Pharma Incorporated (“the Company”), a specialty pharmaceutical company, today announced that Dr. Marijn Dekkers has become a strategic advisor to the Company. Concurrent, with his advisory role, Dr. Dekkers also made an investment in BioQ Pharma through his advisory and investment vehicle Novalis LifeScience LLC. 

Dr. Dekkers is currently the Chairman of Unilever and the Founder and Chairman of Novalis LifeSciences LLC, an investment and advisory firm for the life science industry. He served as CEO of Bayer AG, a global life sciences company, from 2010 to 2016 and as CEO of Thermo Fisher Scientific Inc., a global leader in the manufacturing of laboratory instruments, from 2002 to 2009. Prior to that time, he managed various business units at Honeywell International. Originally from The Netherlands, Dr. Dekkers started his career working as a scientist at General Electric. He holds a Ph.D. and M.S. in chemical engineering from the University of Eindhoven and a B.S. in chemistry from the Radboud University, both in The Netherlands.

Josh Kriesel, President and CEO of BioQ Pharma, said, “We are honored to have Dr. Dekkers as a formal advisor and investor in the Company. His distinguished track record of building shareholder value at both Thermo Fisher Scientific and Bayer will be an invaluable asset to BioQ.


About BioQ Pharma

BioQ Pharma Incorporated is a privately held specialty pharmaceutical company focused on developing and commercializing ready-to-use infusible pharmaceuticals. The Company's infusion platform is intended to address some of the most pressing unmet needs in drug infusion today: cost, medication error, sterility, efficiency, and patient quality of life. BioQ Pharma's vision is to set a new standard of care in the presentation and administration of infusible pharmaceuticals via the Company's proprietary unit-dose infusion systems that can be deployed quickly and conveniently at the point of care with one touch. The Company is ISO13485 certified. BioQ Pharma's commercial collaborators and strategic partners include Novartis' Sandoz unit, Stada, Cipla, Lee's Pharm, Lunatus, Galen Limited, POA Pharma, Sophos Biotech, Xantis Pharma, and West Pharmaceutical Services.  


Company Contact Information:

Josh Kriesel                   
BioQ Pharma Incorporated
President and CEO         
+1-415-336-6496                                                 

Ron Pauli
BioQ Pharma Incorporated
Chief Financial Officer
+1-415-889-7707